Results 151 to 160 of about 38,104 (229)

A clue hidden in plain sight. [PDF]

Eur Heart J Case Rep
Faheem Y, Merves S, Almasri M.
europepmc   +1 more source

Drug-related pulmonary fibrosis: A real-world pharmacovigilance study of the FDA Adverse Event Reporting System. [PDF]

Medicine (Baltimore)
Jian R, Yang L, Guo J, Shi E, Du M, Jin H, Zhen H.   +6 more
europepmc   +1 more source

Recurrent syncope due to ischemic ventricular tachycardia masquerading as a seizure disorder treated with coronary revascularization: a case report. [PDF]

Oxf Med Case Reports
Gebreselassie MA, Alemayehu B, Solela G.
europepmc   +1 more source

Therapeutic Potential of Cannabinoids in Attenuating Amiodarone-Induced Pulmonary Fibrosis: An in vivo Experimental Study in Wistar Rats. [PDF]

Drug Des Devel Ther
Almalki RS.
europepmc   +1 more source

Prolonged ventricular fibrillation treated with nifekalant in fulminant myocarditis following late-onset coronavirus disease 2019. [PDF]

BMJ Case Rep
Ojima S, Kubozono T, Kawabata T, Kawasoe S, Yamaguchi S, Enokida Y, Mukai S, Kanda D, Ohishi M.   +8 more
europepmc   +1 more source

Chagas disease and amiodarone: a bibliometric and systematic review from cell to patient. [PDF]

Front Pharmacol
Barbosa JMC, Duarte RB, Veloso HH, Daliry A, Salomão K.   +4 more
europepmc   +1 more source

Network pharmacology and molecular docking reveal mechanisms of amiodarone-induced pulmonary fibrosis. [PDF]

Sci Rep
Li H, Di R, Kong D.
europepmc   +1 more source

Delayed-Onset Amiodarone Induced Thyrotoxicosis After Glucagon-Like Peptide-1 Agonist-Related Weight Loss. [PDF]

JCEM Case Rep
Black ML, Coyle CG, Bernet VJ, McLeod CJ, Chindris AM.   +4 more
europepmc   +1 more source

The 'shark fin sign' - a morbid and rare electrocardiographic presentation in takotsubo cardiomyopathy. [PDF]

Eur Heart J Case Rep
Hamideh M, Janjua A, Golzarian H.
europepmc   +1 more source